Production of α-galactosylceramide by a prominent member of the human gut microbiota
about
Recognition of Microbial Glycolipids by Natural Killer T CellsDonor Unrestricted T Cells: A Shared Human T Cell ResponseCoevolution of T-cell receptors with MHC and non-MHC ligandsRegulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic PotentialsHUMAN MICROBIOTA. Small molecules from the human microbiotaiNKT and MAIT Cell Alterations in DiabetesControl of intestinal homeostasis through crosstalk between natural killer T cells and the intestinal microbiotaγδ T cell surveillance via CD1 moleculesAnimals in a bacterial world: opportunities for chemical ecologyThe regulatory role of invariant NKT cells in tumor immunityCD1d-lipid antigen recognition by the γδ TCRAcute graft-versus-host disease: a bench-to-bedside update.Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel DiseaseMicrobial, host and xenobiotic diversity in the cystic fibrosis sputum metabolomeCommensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system.CD1: A Singed Cat of the Three Antigen Presentation Systems.Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential.Synthesis of the rosette-inducing factor RIF-1 and analogs.Mining the human gut microbiota for effector strains that shape the immune system.A systematic analysis of biosynthetic gene clusters in the human microbiome reveals a common family of antibiotics.Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction.Deciphering the tête-à-tête between the microbiota and the immune system.Anatomical localization of commensal bacteria in immune cell homeostasis and diseaseThe microbiota, chemical symbiosis, and human disease.Determining microbial products and identifying molecular targets in the human microbiome.Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 dietThe microbiome and regulation of mucosal immunity.Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis.Microbiota-mediated inflammation and antimicrobial defense in the intestine.The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsAn integrative view of microbiome-host interactions in inflammatory bowel diseasesMicrobiota and host immune responses: a love-hate relationship.The Alpha and Omega of Galactosylceramides in T Cell Immune Function.The biliary epithelium presents antigens to and activates natural killer T cellsCD1d-restricted peripheral T cell lymphoma in mice and humans.Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection.Synthesis of Sphingolipids Impacts Survival of Porphyromonas gingivalis and the Presentation of Surface Polysaccharides.Symbiont-derived sphingolipids modulate mucosal homeostasis and B cells in teleost fishTargeting Innate-Like T Cells in Tuberculosis.Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells
P2860
Q26795468-14508BAF-8F68-49B1-8589-DED10E37602AQ26795657-81BD3D9F-6171-465F-83C5-D6AC63A0AEBCQ26797242-B9F17269-3C7F-448D-BCED-F1B63A717942Q26797333-2F51E841-7E31-419E-BED9-5B3EB6ED0BF6Q26799980-515CEA23-FDB7-455D-8CFC-10BAFF81D354Q26801962-47009318-FDA1-481B-A040-1A82DDE5D453Q26825320-EDE945B4-7232-4EE5-ADDF-AB01C0F06833Q26852046-7B5F7A10-B2D9-4AEA-9919-7B9B491313B6Q27011275-45B6D0CD-238E-4663-BC05-F43B78DAC7DBQ27023425-C5E6569C-C645-439C-B982-4C60E466281BQ27686847-E4607EDA-A9BF-421D-A295-0BA5FACD03E1Q27687130-342324BE-8DFB-4C2E-99C6-0EC5EC53619AQ28073700-590074A9-1507-4C5A-B2BC-D9F535B67C50Q28829667-0F1145F6-556E-4986-9F96-76264E21D579Q31169542-2F2C5297-A0E4-4C94-BDCC-A9253430C175Q33695019-EDE1D799-E008-4629-BEBC-827E2F45169FQ33720359-3C9485E4-667B-44F0-A494-09434B4033B6Q33951210-C6FF53E4-0EF6-41CD-BE4B-EAC26870654BQ33988531-18A48653-CEAC-44A0-801A-32844A7F422BQ34181822-09C93330-9577-4753-AE6D-5BF1CFD2B3EFQ34218428-96526C9D-3937-4872-892D-17F5736BBC75Q34311731-0C6B547B-2A95-42E0-9DF3-ACAF8EE55D0CQ34425509-0E147C4F-415D-4C35-ABC7-24A5F3618018Q34616219-0622F768-818D-44CE-AAE5-E9EA36FA542DQ34625923-CEE96017-95F8-45D1-A354-D247007BF615Q34677228-4FB56F6B-C311-4FD7-B4C7-224EA824AC29Q35065019-2059331F-E2EB-498F-A0F7-AA3255CF1076Q35539983-A7C4B5F7-1783-47D6-948A-45B01CD12F26Q35541605-6746BE5C-2B1F-4D91-985E-0E5F42D158E9Q35600087-4C5AE2C9-6877-4601-B543-2358964B3336Q35631737-9E8BE22A-083B-483A-8B38-9CBCF5EAB0E6Q35800234-D2090E6C-430A-46BA-B82F-EA2D6F8495BFQ35860595-6C78FC1D-D7A4-400F-A45A-83800B7E7668Q36108867-6483A0FC-4B2A-4C8A-A8E0-5E77A1899AC0Q36863110-3417A32E-4CA0-4E70-80BC-8B3385E184B1Q37317771-296D0090-2287-481C-91A3-7E1AA8897E12Q37447311-B267F29B-782F-4AF9-A4F9-64038AAE8EA5Q37501281-07C2269B-80DF-4A90-9141-6C2AC0D3840AQ37522519-59AE1A9B-0A22-4C2F-AF05-AD3253DCB6A2Q37539899-AA918422-3657-4404-8FFD-621F778DAE54
P2860
Production of α-galactosylceramide by a prominent member of the human gut microbiota
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@ast
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@en
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@nl
type
label
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@ast
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@en
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@nl
prefLabel
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@ast
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@en
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@nl
P2093
P2860
P3181
P1433
P1476
Production of α-galactosylceramide by a prominent member of the human gut microbiota
@en
P2093
Brianna B Williams
Cristina Penaranda
Jeffrey A Bluestone
Jon Clardy
Justin L Sonnenburg
Laura C Wieland Brown
Laurie E Comstock
Michael A Fischbach
Purna C Kashyap
P2860
P304
P3181
P356
10.1371/JOURNAL.PBIO.1001610
P407
P577
2013-07-01T00:00:00Z